Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinoplasty | 9 | 2023 | 238 | 3.490 |
Why?
|
Facial Paralysis | 8 | 2023 | 345 | 2.700 |
Why?
|
Alopecia | 5 | 2024 | 414 | 2.680 |
Why?
|
Platelet-Rich Plasma | 3 | 2024 | 179 | 1.840 |
Why?
|
Cosmetic Techniques | 2 | 2023 | 148 | 1.340 |
Why?
|
Hair | 3 | 2022 | 497 | 1.130 |
Why?
|
Minoxidil | 1 | 2024 | 34 | 0.920 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2018 | 465 | 0.890 |
Why?
|
Finasteride | 1 | 2024 | 90 | 0.860 |
Why?
|
Nasal Obstruction | 3 | 2020 | 159 | 0.810 |
Why?
|
Osteotomy | 2 | 2017 | 836 | 0.780 |
Why?
|
Parotid Neoplasms | 1 | 2023 | 157 | 0.780 |
Why?
|
Otolaryngology | 3 | 2021 | 685 | 0.690 |
Why?
|
Tissue Transplantation | 1 | 2020 | 128 | 0.680 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 482 | 0.680 |
Why?
|
Patient Satisfaction | 3 | 2023 | 3446 | 0.660 |
Why?
|
Botulinum Toxins | 1 | 2020 | 187 | 0.640 |
Why?
|
Pain, Postoperative | 5 | 2023 | 1721 | 0.620 |
Why?
|
Face | 3 | 2021 | 1017 | 0.600 |
Why?
|
Rhytidoplasty | 1 | 2018 | 68 | 0.590 |
Why?
|
Nasal Bone | 1 | 2017 | 57 | 0.580 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.540 |
Why?
|
Quality of Life | 3 | 2023 | 13286 | 0.530 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 373 | 0.500 |
Why?
|
Health Literacy | 1 | 2020 | 441 | 0.490 |
Why?
|
Contact Tracing | 1 | 2017 | 271 | 0.490 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 557 | 0.480 |
Why?
|
Analgesics, Opioid | 5 | 2023 | 3765 | 0.460 |
Why?
|
Occupational Health | 1 | 2020 | 805 | 0.450 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.430 |
Why?
|
Facial Nerve Injuries | 1 | 2013 | 64 | 0.430 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.420 |
Why?
|
Rhinitis | 2 | 2011 | 746 | 0.420 |
Why?
|
Indocyanine Green | 1 | 2014 | 236 | 0.420 |
Why?
|
Insurance Coverage | 2 | 2020 | 1933 | 0.400 |
Why?
|
Videotape Recording | 1 | 2013 | 337 | 0.380 |
Why?
|
Sinusitis | 2 | 2011 | 990 | 0.380 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2011 | 42 | 0.370 |
Why?
|
Insurance, Health | 2 | 2020 | 2495 | 0.370 |
Why?
|
Free Tissue Flaps | 2 | 2013 | 327 | 0.370 |
Why?
|
Facial Dermatoses | 1 | 2011 | 85 | 0.360 |
Why?
|
Intraoperative Care | 1 | 2014 | 766 | 0.360 |
Why?
|
Facial Bones | 1 | 2011 | 205 | 0.360 |
Why?
|
Epistaxis | 1 | 2011 | 111 | 0.360 |
Why?
|
Paranasal Sinus Diseases | 1 | 2011 | 121 | 0.350 |
Why?
|
Attitude to Health | 1 | 2018 | 2025 | 0.340 |
Why?
|
Maxillary Sinus | 1 | 2011 | 180 | 0.330 |
Why?
|
Granuloma | 1 | 2011 | 327 | 0.320 |
Why?
|
Reoperation | 1 | 2018 | 4282 | 0.310 |
Why?
|
Eye Neoplasms | 1 | 2010 | 306 | 0.300 |
Why?
|
Lacrimal Apparatus | 1 | 2010 | 223 | 0.300 |
Why?
|
Florida | 2 | 2018 | 431 | 0.290 |
Why?
|
Surgical Flaps | 2 | 2023 | 1669 | 0.280 |
Why?
|
Health Care Costs | 1 | 2020 | 3245 | 0.280 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1897 | 0.270 |
Why?
|
Hematoma | 1 | 2011 | 768 | 0.260 |
Why?
|
New York | 2 | 2018 | 874 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2359 | 0.240 |
Why?
|
Tuberculosis | 1 | 2017 | 2001 | 0.240 |
Why?
|
Postoperative Period | 2 | 2020 | 1812 | 0.230 |
Why?
|
Patient Readmission | 1 | 2018 | 3261 | 0.230 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 503 | 0.230 |
Why?
|
Quality-Adjusted Life Years | 2 | 2022 | 1722 | 0.230 |
Why?
|
Humans | 43 | 2024 | 758381 | 0.230 |
Why?
|
Taiwan | 3 | 2017 | 504 | 0.220 |
Why?
|
Mandibular Nerve | 1 | 2023 | 59 | 0.220 |
Why?
|
Male | 27 | 2024 | 358742 | 0.210 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1526 | 0.210 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2024 | 117 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Bacteremia | 1 | 2008 | 980 | 0.190 |
Why?
|
Orthopedic Procedures | 1 | 2011 | 1263 | 0.190 |
Why?
|
Acetaminophen | 2 | 2023 | 552 | 0.190 |
Why?
|
Hypoglycemia | 1 | 2008 | 881 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1402 | 0.190 |
Why?
|
Female | 24 | 2024 | 390316 | 0.180 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2016 | 286 | 0.180 |
Why?
|
Endoscopy | 1 | 2010 | 1834 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.180 |
Why?
|
Beauty | 1 | 2020 | 41 | 0.180 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2882 | 0.170 |
Why?
|
Pain Measurement | 2 | 2020 | 3527 | 0.170 |
Why?
|
Prospective Studies | 5 | 2023 | 54136 | 0.170 |
Why?
|
Postoperative Complications | 2 | 2020 | 15638 | 0.170 |
Why?
|
Adult | 19 | 2023 | 219916 | 0.170 |
Why?
|
Health Care Sector | 1 | 2021 | 193 | 0.170 |
Why?
|
Fractures, Bone | 1 | 2011 | 2040 | 0.170 |
Why?
|
Anti-Anxiety Agents | 1 | 2022 | 397 | 0.160 |
Why?
|
Kentucky | 1 | 2018 | 84 | 0.160 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7810 | 0.160 |
Why?
|
Iowa | 1 | 2018 | 103 | 0.160 |
Why?
|
Ear Cartilage | 1 | 2018 | 62 | 0.160 |
Why?
|
Oxycodone | 1 | 2019 | 138 | 0.150 |
Why?
|
Esthetics | 1 | 2020 | 326 | 0.150 |
Why?
|
North Carolina | 1 | 2018 | 323 | 0.150 |
Why?
|
Michigan | 1 | 2018 | 341 | 0.150 |
Why?
|
Thyroid Neoplasms | 1 | 2011 | 2332 | 0.150 |
Why?
|
Authorship | 1 | 2020 | 281 | 0.140 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 156 | 0.140 |
Why?
|
Pilot Projects | 3 | 2017 | 8554 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2020 | 393 | 0.140 |
Why?
|
Injections | 1 | 2020 | 830 | 0.140 |
Why?
|
Reading | 1 | 2020 | 529 | 0.140 |
Why?
|
Surgery, Plastic | 1 | 2023 | 643 | 0.130 |
Why?
|
Medicare Part D | 1 | 2021 | 353 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8946 | 0.130 |
Why?
|
Tonsillar Neoplasms | 1 | 2016 | 50 | 0.130 |
Why?
|
Middle Aged | 16 | 2023 | 219560 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 619 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2021 | 58681 | 0.120 |
Why?
|
Databases, Factual | 3 | 2021 | 7980 | 0.120 |
Why?
|
Skin Transplantation | 1 | 2020 | 1083 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2023 | 80170 | 0.120 |
Why?
|
California | 1 | 2018 | 1419 | 0.120 |
Why?
|
Blepharoplasty | 1 | 2014 | 60 | 0.120 |
Why?
|
China | 1 | 2020 | 2337 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25953 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2020 | 1475 | 0.110 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8530 | 0.110 |
Why?
|
Medicare | 2 | 2023 | 6741 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2114 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2270 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 3 | 2011 | 20500 | 0.110 |
Why?
|
Cadaver | 1 | 2017 | 1345 | 0.110 |
Why?
|
Synkinesis | 1 | 2013 | 23 | 0.110 |
Why?
|
Eyelid Diseases | 1 | 2014 | 157 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2009 | 831 | 0.100 |
Why?
|
Aged | 11 | 2023 | 168217 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 927 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1436 | 0.090 |
Why?
|
Eyelids | 1 | 2013 | 277 | 0.090 |
Why?
|
Angiofibroma | 1 | 2011 | 55 | 0.090 |
Why?
|
Sputum | 2 | 2009 | 502 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 536 | 0.080 |
Why?
|
Hyperpigmentation | 1 | 2011 | 117 | 0.080 |
Why?
|
Qualitative Research | 1 | 2020 | 2976 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 608 | 0.080 |
Why?
|
Video Recording | 1 | 2014 | 954 | 0.080 |
Why?
|
Facial Expression | 1 | 2013 | 508 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2014 | 559 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3082 | 0.080 |
Why?
|
Serotyping | 1 | 2008 | 324 | 0.080 |
Why?
|
Mycobacterium | 1 | 2009 | 250 | 0.070 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 36285 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1900 | 0.070 |
Why?
|
Cohort Studies | 3 | 2017 | 41252 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2600 | 0.070 |
Why?
|
Adolescent | 7 | 2017 | 87888 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3701 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2023 | 64379 | 0.060 |
Why?
|
Respiratory System | 1 | 2009 | 557 | 0.060 |
Why?
|
Chronic Disease | 2 | 2011 | 9266 | 0.060 |
Why?
|
Young Adult | 6 | 2017 | 58808 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3362 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12951 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12440 | 0.060 |
Why?
|
Internship and Residency | 2 | 2017 | 5865 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
Graft Survival | 1 | 2014 | 3794 | 0.060 |
Why?
|
Wound Healing | 1 | 2014 | 2783 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 732 | 0.050 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2010 | 800 | 0.050 |
Why?
|
United States | 5 | 2023 | 72140 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5403 | 0.050 |
Why?
|
Child | 4 | 2017 | 79813 | 0.050 |
Why?
|
Infant | 2 | 2017 | 36054 | 0.050 |
Why?
|
Child, Preschool | 2 | 2017 | 42058 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2009 | 1373 | 0.050 |
Why?
|
Feminization | 1 | 2020 | 18 | 0.050 |
Why?
|
Incidence | 1 | 2018 | 21273 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8426 | 0.040 |
Why?
|
Patient Advocacy | 1 | 2020 | 360 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6768 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11070 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2023 | 1673 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 26182 | 0.040 |
Why?
|
Transsexualism | 1 | 2020 | 206 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5797 | 0.030 |
Why?
|
Blood Glucose | 1 | 2008 | 6347 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15225 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7377 | 0.030 |
Why?
|
Medicine | 1 | 2021 | 942 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13959 | 0.030 |
Why?
|
Drug Costs | 1 | 2021 | 1179 | 0.030 |
Why?
|
Time Factors | 2 | 2011 | 39873 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15785 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20052 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 15646 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2889 | 0.020 |
Why?
|
Ethambutol | 1 | 2009 | 59 | 0.020 |
Why?
|
Pyrazinamide | 1 | 2009 | 60 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2675 | 0.020 |
Why?
|
Isoniazid | 1 | 2009 | 283 | 0.020 |
Why?
|
Rifampin | 1 | 2009 | 339 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4538 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2009 | 748 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2142 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8823 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2417 | 0.020 |
Why?
|
Registries | 1 | 2019 | 8176 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39060 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8057 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2055 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6293 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 6955 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 73806 | 0.010 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_